Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Inventory (2022 - 2025)

Historic Change in Inventory for InMed Pharmaceuticals (INM) over the last 4 years, with Q3 2025 value amounting to -$70366.0.

  • InMed Pharmaceuticals' Change in Inventory fell 19015.71% to -$70366.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$329266.0, marking a year-over-year decrease of 20980.73%. This contributed to the annual value of -$283151.0 for FY2025, which is 32759.14% down from last year.
  • InMed Pharmaceuticals' Change in Inventory amounted to -$70366.0 in Q3 2025, which was down 19015.71% from $147203.0 recorded in Q2 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Change in Inventory peaked at $1.1 million during Q2 2022, and registered a low of -$390329.0 during Q3 2023.
  • Its 4-year average for Change in Inventory is $34448.9, with a median of -$70366.0 in 2025.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 39908.55% in 2024, then tumbled by 19015.71% in 2025.
  • Quarter analysis of 4 years shows InMed Pharmaceuticals' Change in Inventory stood at -$165017.0 in 2022, then plummeted by 31.98% to -$217784.0 in 2023, then skyrocketed by 46.41% to -$116717.0 in 2024, then skyrocketed by 39.71% to -$70366.0 in 2025.
  • Its last three reported values are -$70366.0 in Q3 2025, $147203.0 for Q2 2025, and -$289386.0 during Q1 2025.